An exceptional global event entirely dedicated to breakthrough biomarker investigations and combination therapies for cancer. Major developments in precision cancer medicine will be developed in sessions featuring basic and clinical cancer research:
Molecular analysis of immune cells and immunotherapy
What can we learn from hemato-oncology?
Tumor cells plasticity and druggable targets
Combination of targeted therapies
New findings in fundamental mechanisms in pediatric solid and liquid cancers
Blood and body fluids – non-invasive investigations in oncology